← The Wire
ANLNasdaq
Adlai Nortye Ltd.
Pharmaceutical Preparations · DE · CIK 1944552
Adlai Nortye Ltd. develops and markets oncology drug candidates, facing risks from adverse events and regulatory scrutiny
$665M
Market cap
$11.41
Last close
+14.1%
1D
+9.7%
5D
203K
Volume
Price · last 39 sessions-23.8%
May 4L $9.95 · H $14.97Jun 29
27
Total filings
Apr 16, 2026
Last filing
12/31
Fiscal year end
6-KREPORT OF FOREIGN PRIVATE ISSUERApr 16, 202620-FANNUAL REPORTApr 10, 20266-KREPORT OF FOREIGN PRIVATE ISSUERApr 1, 20266-KREPORT OF FOREIGN PRIVATE ISSUERFeb 12, 20266-KREPORT OF FOREIGN PRIVATE ISSUERFeb 3, 20266-KREPORT OF FOREIGN PRIVATE ISSUERDec 29, 20256-KREPORT OF FOREIGN PRIVATE ISSUERDec 29, 20256-KREPORT OF FOREIGN PRIVATE ISSUERDec 3, 20256-KREPORT OF FOREIGN PRIVATE ISSUEROct 22, 20256-KREPORT OF FOREIGN PRIVATE ISSUERJul 9, 20256-KREPORT OF FOREIGN PRIVATE ISSUERMay 30, 202520-FANNUAL REPORTApr 30, 20256-KREPORT OF FOREIGN PRIVATE ISSUERFeb 14, 20256-KREPORT OF FOREIGN PRIVATE ISSUERDec 31, 20246-KFORM 6-KAug 8, 20246-KFORM 6-KJul 3, 20246-KFORM 6-KJun 27, 20246-KFORM 6-KMay 24, 202420-FFORM 20-FApr 19, 20246-KFORM 6-KApr 2, 2024SC 13GSC 13GMar 4, 2024SC 13GSC 13GFeb 15, 2024SC 13GSC 13GFeb 15, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GJan 31, 2024SC 13GSC 13GOct 13, 2023424B4424B4Sep 29, 2023
Similar companies
Comparable business profile · signals at a glance